Pharmacokinetic Comparison of Scutellarin and Paeoniflorin in Sham-Operated and Middle Cerebral Artery Occlusion Ischemia and Reperfusion Injury Rats after Intravenous Administration of Xin-Shao Formula

Molecules. 2016 Sep 7;21(9):1191. doi: 10.3390/molecules21091191.

Abstract

Xin-Shao formula is a folk remedy widely used in China to prevent and cure stroke. Cerebral ischemic reperfusion (I/R) injury often takes place during the treatment of stroke. Information about the pharmacokinetic behavior of the remedy under cerebral I/R injury conditions is lacking. The present study aimed to compare the pharmacokinetic properties of scutellarin and paeoniflorin, two major bioactive components of Xin-Shao formula, under physiological state in cerebral I/R injury rats. Neurobehavioral dysfunction was evaluated and cerebral infarcted volume was measured in middle cerebral artery occlusion I/R injury (MCAO) rats. Plasma samples were collected at various time points after a single dose (intravenous, i.v.) of Xin-Shao formula. The levels of plasma scutellarin and paeoniflorin at the designed time points were determined by a UPLC-MS/MS method, and drug concentration versus time plots were constructed to estimate pharmacokinetic parameters. Increase in terminal elimination half-life (t1/2z) and mean residence time (MRT(0-t)) of scutellarin as well as elevation in area under the plasma drug concentration-time curve from 0 h to the terminal time point (AUC(0-t)) and maximum plasma drug concentration (Cmax) of paeoniflorin, along with decreased clearance of paeoniflorin and scutellarin as well as reduced apparent volume of distribution (Vz) of paeoniflorin, were observed in MCAO rats, compared with those in sham-operated animals. The elimination of scutellarin and paeoniflorin were reduced in cerebral I/R injury reduced rats.

Keywords: MCAO; UPLC-MS/MS; Xin-Shao formula; paeoniflorin; pharmacokinetics; scutellarin.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Apigenin* / chemistry
  • Apigenin* / pharmacokinetics
  • Apigenin* / pharmacology
  • Disease Models, Animal
  • Glucosides* / chemistry
  • Glucosides* / pharmacokinetics
  • Glucosides* / pharmacology
  • Glucuronates* / chemistry
  • Glucuronates* / pharmacokinetics
  • Glucuronates* / pharmacology
  • Infarction, Middle Cerebral Artery* / drug therapy
  • Infarction, Middle Cerebral Artery* / metabolism
  • Infarction, Middle Cerebral Artery* / physiopathology
  • Male
  • Medicine, Chinese Traditional
  • Monoterpenes* / chemistry
  • Monoterpenes* / pharmacokinetics
  • Monoterpenes* / pharmacology
  • Plant Extracts* / chemistry
  • Plant Extracts* / pharmacokinetics
  • Plant Extracts* / pharmacology
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury* / drug therapy
  • Reperfusion Injury* / metabolism
  • Reperfusion Injury* / physiopathology
  • Stroke* / drug therapy
  • Stroke* / metabolism
  • Stroke* / physiopathology

Substances

  • Glucosides
  • Glucuronates
  • Monoterpenes
  • Plant Extracts
  • scutellarin
  • peoniflorin
  • Apigenin